Reinsurance Group of America Inc

Reinsurance Group of America Inc(RGA)股票分析

$266.800

+0.053 (+0.02%)收盤時

Loading chart…
最高
268.316
開盤
265.410
成交量加權均價
266.48
成交量
405.87K
市值
13.56B
最低
264.315
成交金額
108.15M
企業價值/稅息折舊攤銷前利潤(TTM)
5.93

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.

AI 分析 of Reinsurance Group of America Inc (RGA)

買進

Reinsurance Group of America Inc is a good buy right now due to its strong financial performance, including a recent EPS of $8.89 which exceeded expectations by $2.40, and a forward P/E ratio of 7.716, indicating potential for growth. Additionally, the stock has shown a 31.12% year-to-date change and a 41.56% increase over the past year, reflecting robust market demand. However, a risk to consider is the high RSI of 85.29, suggesting that the stock may be overbought in the short term.

分析師評級(9)

-9.17% 下跌空間
持有
2 買進
6 持有
1 賣出
目前: 266.80
最低
208.00
平均
242.33
最高
275.00

Barclays

2026-10-08

目標價

$292

增持

Barclays

2026-10-07

目標價

$286

增持

Morgan Stanley

2026-09-28

目標價

$295

增持

Morgan Stanley

2026-08-24

目標價

$250

Equal Weight

Wells Fargo

2026-08-19

目標價

$291

增持

估值指標

Reinsurance Group of America Inc(RGA)目前預期本益比為 7.72,5 年平均預期本益比為 8.85。

預期本益比

合理
5 年均值 P/E
8.85
目前P/E
7.72
高估
10.91
低估
6.79

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
0.71
目前EV/EBITDA
5.93
高估
2.66
低估
-1.25

預期股價營收比

高估
5 年均值 P/S
0.53
目前P/S
0.62
高估
0.59
低估
0.47

Alphio AI 對 RGA 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%RGA

$214.60

情境價格

基

基準

基準 · 50%RGA

$208.51

情境價格

悲

悲觀

悲觀 · 25%RGA

$183.89

情境價格

持有 RGA 的大戶

S

South Dakota Investment Council

+ 持有RGA

+5.18%

3個月報酬率

P

Prana Capital Management LP

+ 持有RGA

+1.01%

3個月報酬率

B

Bahl & Gaynor, Inc.

+ 持有RGA

+0.51%

3個月報酬率

F

Freestone Grove Partners LP

+ 持有RGA

-2.23%

3個月報酬率

E

EARNEST Partners, LLC

+ 持有RGA

-5.52%

3個月報酬率

RGA 常見問題 —— 由 Alphio AI 解答

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements. It operates in the Financials sector (LIFE INSURANCE industry).

Reinsurance Group of America Inc is a good buy right now due to its strong financial performance, including a recent EPS of $8.89 which exceeded expectations by $2.40, and a forward P/E ratio of 7.716, indicating potential for growth. Additionally, the stock has shown a 31.12% year-to-date change and a 41.56% increase over the past year, reflecting robust market demand. However, a risk to consider is the high RSI of 85.29, suggesting that the stock may be overbought in the short term.

9 analysts cover RGA: 2 rate it Buy, 6 Hold and 1 Sell. The average price target is 242.33.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易